Responses
Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
58 Excluding treg epitopes and integrating CD8 and CD4 effector neoepitope content improves prognostic biomarker tool in bladder cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
